Showing results (131-140 of 251) with videos related to

Sort By:
Pageof 26
Oncology Reports|December 17, 2008
The pro-angiogenic factors stimulated by human papillomavirus type 16 E6 and E7 protein in C33A and human fibroblastsLing Xi, Shixuan Wang, Changyu Wang, et al.
Frontiers in Pharmacology|March 27, 2023
Adenosine and P1 receptors: Key targets in the regulation of sleep, torpor, and hibernationWei-Xiang Ma, Ping-Chuan Yuan, Hui Zhang, et al.
Materials Today. Bio|June 9, 2025
TMTP1-modified polymeric micelles for the inhibition of ovarian cancer metastasis and recurrence through enhanced photothermal-immunotherapyLing Wang, Jie Li, Danya Zhang, et al.
Molecular Plant Pathology|January 27, 2024
A natural substitution of a conserved amino acid in eIF4E confers resistance against multiple potyvirusesLing-Xi Zhou, Yan-Ping Tian, Li-Li Ren, et al.
Theranostics|April 30, 2025
TMTP1-modified nanocarrier boosts cervical cancer immunotherapy by eliciting pyroptosisHanjie Xu, Danya Zhang, Yu Zhang, et al.
Melanoma Research|December 3, 2003
Use of multiple cytometric markers improves discrimination between benign and malignant melanocytic lesions: a study of DNA microdensitometry, karyometry, argyrophilic staining of nucleolar organizer regions and MIB1-Ki67 immunoreactivityLing-Xi L Li, Kerry A Crotty, Richard A Scolyer, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|October 9, 2019
Targeted co-delivery of Trp-2 polypeptide and monophosphoryl lipid A by pH-sensitive poly (β-amino ester) nano-vaccines for melanomaChenming Zou, Guiying Jiang, Xueqin Gao, et al.
The American Journal of Dermatopathology|May 31, 2003
Argyrophilic staining of nucleolar organizer region count and morphometry in benign and malignant melanocytic lesionsLing-Xi L Li, Kerry A Crotty, Allan A Palmer, et al.
International Journal of Biomedical Science : IJBS|May 16, 2013
Clinicopathological Significance of VEGF-C, VEGFR-3 and Cyclooxygenase-2 in Early-Stage Cervical CancerXiaoyan Shi, Ling Xi, Danhui Weng, et al.
Cancer Biotherapy & Radiopharmaceuticals|December 24, 2024
Identification of a Vascular Endothelial Growth Factor Receptor-3 Binding Peptide TMVP1 for Enhancing Drug Delivery Efficiency and Therapeutic Efficacy Against Tumor LymphangiogenesisTeng Cheng, Fei Li, Zhenzhong Zhang, et al.
Pageof 26